Company Filing History:
Years Active: 2017
Title: Ure Egerland: Innovator in Phosphodiesterase Inhibition
Introduction
Ure Egerland is a notable inventor based in Radebeul, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target phosphodiesterases. His work is crucial for advancing treatments for central nervous system diseases.
Latest Patents
Ure Egerland holds a patent for (1,2,4)triazolo[4,3-A]quinoxaline derivatives as inhibitors of phosphodiesterases. This invention relates to compounds that inhibit phosphodiesterase 2 and/or 10, which are useful in treating various central nervous system disorders. His innovative approach has the potential to lead to new therapeutic options for patients.
Career Highlights
Egerland is associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His role there has allowed him to work on cutting-edge research and development projects that aim to improve health outcomes through innovative drug design.
Collaborations
Throughout his career, Ure Egerland has collaborated with esteemed colleagues, including Hans-Joachim Lankau and Barbara Langen. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Ure Egerland's contributions to the field of medicinal chemistry, particularly through his patent on phosphodiesterase inhibitors, highlight his role as an influential inventor. His work continues to pave the way for advancements in treating central nervous system diseases.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.